"10.1371_journal.pone.0039416","plos one","2012-06-25T00:00:00Z","Sambasiva P Rao; Jose Sancho; Juanita Campos-Rivera; Paula M Boutin; Peter B Severy; Timothy Weeden; Srinivas Shankara; Bruce L Roberts; Johanne M Kaplan","Neuroimmunology Research, Genzyme, A Sanofi Company, Framingham, Massachusetts, United States of America; Immune Mediated Disease Biology Research, Genzyme, A Sanofi Company, Framingham, Massachusetts, United States of America","Conceived and designed the experiments: SPR SS BR. Performed the experiments: SPR JS JCR PMB PBS TW. Analyzed the data: SPR. Contributed reagents/materials/analysis tools: SPR JS JCR PMB TW. Wrote the paper: SPR JK.","All the authors are employees of Genzyme, from which they receive compensation. Alemtuzumab is in clinical development by Genzyme. This does not alter the authors' adherence to all the PLoS ONE policies on sharing the data and materials.","2012","06","Sambasiva P Rao","SPR",9,TRUE,3,6,1,2,TRUE,TRUE,FALSE,0,NA,FALSE
